E.U. Agency in Limbo as Hidden Costs of ‘Brexit’ Continue to Mount

Thursday, December 29, 2016 - 16:21 in Mathematics & Economics

The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country’s vibrant biotech and pharmaceuticals sector.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net